<DOC>
	<DOCNO>NCT00000894</DOCNO>
	<brief_summary>To compare cidofovir commonly use treatment regimen , ganciclovir give mouth ( oral ) eye device ( intraocular ) , order determine safety effectiveness cidofovir prevent vision loss patient AIDS complicate CMV ( cytomegalovirus ) retinitis . Cidofovir need compare ganciclovir determine best way treat CMV retinitis .</brief_summary>
	<brief_title>Comparison Two Drugs , Cidofovir Ganciclovir , Treating Patients With AIDS Who Have CMV Retinitis</brief_title>
	<detailed_description>While cidofovir effective suppress retinitis prolonging time progression , study compare cidofovir therapy place treatment CMV retinitis remain unexplored . By combine ganciclovir intraocular device ( slow retinitis progression ) oral ganciclovir ( potential treat ocular disease suppress dissemination contralateral eye viscera ) , without use central venous catheter , combination become increasingly common . For reason , comparative trial cidofovir therapy appropriate . After stratified clinic stage disease , patient randomize 1 2 treatment arm : intravenous ( IV ) cidofovir ( Group I ) intraocular ganciclovir device plus oral ganciclovir ( Group II ) . Group I : Cidofovir administer IV weekly 2 consecutive week , every 2 week thereafter . If progression occur , oral ganciclovir add treatment regimen tolerate , patient treat accord best medical judgment . Concurrent oral probenecid intravenous hydration administer cidofovir infusion . Group II : An intraocular ganciclovir device surgically implanted baseline every 6 8 month ganciclovir administer orally . If 1 progression unacceptable toxicity occurs , patient treat accord best medical judgment .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are 13 year age older ( parent guardian consent require 18 ) . Agree practice sexual abstinence use effective birth control 90 day study . Have AIDS . Have CMV retinitis . Exclusion Criteria You eligible study : Have history heart kidney disease . Have medical problem would prevent complete study . Are pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>Infusions , Intravenous</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Drug Implants</keyword>
	<keyword>Cytomegalovirus Retinitis</keyword>
	<keyword>Eye</keyword>
	<keyword>cidofovir</keyword>
</DOC>